It's a disease that continues to be of major import to all forms of bovine practice, and whose epidemiology, pathogenesis, treatment and prevention continues to evolve rapidly over time. You don't want to miss this seminar!
Full day webinar
7-9 am**: Bovine viral diarrhea virus. Frank van der Meer, University of Calgary
9-9:30 am: Break
9:30-10:30 am: Clinical aspect of bovine viral diarrhea. Eugene Janzen, University of Calgary
10:30-11:30 am: Pathology of bovine viral diarrhea. Part 1. Ted Clark, University of Calgary
11:30-12:30 pm: Long break
12:30-1:30 pm: Pathology of bovine viral diarrhea. Part 2. Ted Clark, University of Calgary
1:30-2:30 pm: Control of bovine viral diarrhea. Part 1. Paul Walz, Auburn University
2:30-3 pm: Break
3-4 pm: Control of bovine viral diarrhea. Part 2. Paul Walz, Auburn University
4-5 pm: General discussion. Frank van der Meer, Eugene Janzen, Ted Clark, Paul Walz
Learning objectives:
Frank van der Meer:
What is Bovine Viral Diarrhea Virus and how does it behave in its natural hosts
What is the clinical presentation of BVD and discuss the diagnostic options
What is the current status of BVDV eradication and what are the opportunities for North America
Ted Clark:
Learning objectives for my presentation on the pathologic findings of BVD:
1. Recognizing the lesions of primarily transient infections utilizing good herd histories, gross lesions and selection of tissues for histopathology and immunohistochemistry (IHC).
2. Stressing the importance of IHC relative to the histopathologic lesions to gain confidence in your final diagnosis and / or comments in your final reports.
3. If present, vasculitis and perivasculitis in select tissues are hallmark features of transient BVD infections, at least in beef feedlot cattle of Western Canada.
Paul H. Walz
At the completion of this program, the learner will be able to:
1. Identify optimal testing methods for BVDV persistent infection and interpret test results.
2. Explain the merits of modified-live and killed viral vaccines in BVDV control and determine where these vaccines can provide the optimal response.
3. Discuss biocontainment and biosecurity principles as they relate to disease and infection control for BVDV.
*-This seminar is preapproved by the ACVP Maintenance of Certification (MOC) Committee for 4 credits
-This program has been approved for 8 hours of continuing education credit in jurisdictions which recognize RACE approval.
**: all times in PST